Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis

Abstract The use of TNF-α inhibitors for the treatment of moderate to severe psoriasis and psoriatic arthritis is increasingly more frequent. The authors report a case of Guillain-Barré syndrome as a late manifestation of the treatment with adalimumab. Although unusual, this is relevant for professi...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Anais Brasileiros de Dermatologia
المؤلفون الرئيسيون:	Natallia Barreiros de Natividade, Paulo Antonio Oldani Felix, Claudio Lerer
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Sociedade Brasileira de Dermatologia 2017-01-01
الموضوعات:	Arthritis, psoriatic Demyelinating diseases Psoriasis Guillain-Barre syndrome
الوصول للمادة أونلاين:	http://www.scielo.br/pdf/abd/v92n5s1/0365-0596-abd-92-05-s1-0085.pdf